Abstract
Transforming growth factor (TGF)-β has been implicated in regulation of the immune system, including autoimmunity. We have found that TGF-β is readily produced by T cells following immunization with self-peptide epitopes that downregulate autoimmune responses in type 1 diabetes (T1D) prone nonobese diabetic (NOD) mice. These include multiple peptide epitopes derived from the islet β-cell antigens GAD65 (GAD65 p202-221, GAD65 p217-236), GAD67 (GAD67 p210-229, GAD67 p225-244), IGRP (IGRP p123-145, IGRP p195-214) and insulin B-chain (Ins. B:9-23) that protected NOD mice from T1D. Immunization of NOD mice with the self-MHC class II I-Ag7 β-chain-derived peptide, I-Aβg7 p54-76 also induced large amounts of TGF-β and also protected these mice from diabetes development. These results indicate that peptides derived from disease related self-antigens and MHC class II molecules primarily induce TGF-β producing regulatory Th3 and Tr1-like cells. TGF-β produced by these cells could enhance the differentiation of induced regulatory iTreg and iTreg17 cells to prevent induction and progression of autoimmune diseases. We therefore suggest that peripheral immune tolerance could be induced and maintained by immunization with self-peptides that induce TGF-β producing T cells.
Similar content being viewed by others
References
Bach JF (1994) Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 15:516–542
Bach JF, Chatenoud L (2001) Tolerance to islet autoantigens in type 1 diabetes. Annu Rev Immunol 19:131–161
Battaglia M, Gregori S, Bacchetta R et al (2006a) Tr1 cells: from discovery to their clinical application. Semin Immunol 18:120–127
Battaglia M, Stabilini A, Draghici E et al (2006b) Induction of tolerance in type 1 diabetes via both CD4+CD25+T regulatory cells and T regulatory type 1 cells. Diabetes 55:1571–1580
Bellemore SM, Nikoopour E, Schwartz JA et al (2015) Preventative role of interleukin-17 producing regulatory T helper type 17 (Treg 17) cells in type 1 diabetes in non-obese diabetic mice. Clin Exp Immunol 182:261–269
Bluestone JA, Tang Q, Sedwick CE (2008) T regulatory cells in autoimmune diabetes: past challenges, future prospects. J Clin Immunol 28:677–684
Chaturvedi P, Qin HY, Chou H et al (1997) Modulation of insulin-dependent diabetes mellitus (IDDM) in NOD mice by autoreactive T cells. Crit Rev Immunol 17:519–528
Chaturvedi P, Agrawal B, Zechel M et al (2000) A self MHC class II beta-chain peptide prevents diabetes in nonobese diabetic mice. J Immunol 164:6610–6620
Chen Y, Kuchroo VK, Inobe J et al (1994) Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237–1240
Chen C, Lee WH, Yun P et al (2003) Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes. J Immunol 171:733–744
Clemente-Casares X, Blanco J, Ambalavanan P et al (2016) Expanding antigen-specific regulatory networks to treat autoimmunity. Nature 530:434–440
Cottrez F, Hurst SD, Coffman RL et al (2000) T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 165:4848–4853
Daniel D, Wegmann DR (1996) Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc Natl Acad Sci USA 93:956–960
Delong T, Baker RL, He J et al (2013) Novel autoantigens for diabetogenic CD4 T cells in autoimmune diabetes. Immunol Res 55:167–172
Delovitch TL, Singh B (1997) The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7:727–738
Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577–584
Di Lorenzo TP, Peakman M, Roep BO (2007) Translational mini-review series on type 1 diabetes: systematic analysis of T cell epitopes in autoimmune diabetes. Clin Exp Immunol 148:1–16
Elliott JF, Qin HY, Bhatti S et al (1994) Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes 43:1494–1499
Gomez-Tourino I, Arif S, Eichmann M et al (2016) T cells in type 1 diabetes: instructors, regulators and effectors: a comprehensive review. J Autoimmun 66:7–16
Groux H (2003) Type 1 T-regulatory cells: their role in the control of immune responses. Transplantation 75(9 Suppl):8S–12S
Groux H, O’Garra A, Bigler M et al (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737–742
Han HS, Jun HS, Utsugi T et al (1996) A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. J Autoimmun 9:331–339
Han HS, Jun HS, Utsugi T et al (1997) Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice. J Autoimmun 10:299–307
Han B, Serra P, Amrani A et al (2005a) Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide. Nat Med 11:645–652
Han B, Serra P, Yamanouchi J et al (2005b) Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes. J Clin Invest 115:1879–1887
Ishigame H, Zenewicz LA, Sanjabi S et al (2013) Excessive Th1 responses due to the absence of TGF-β signaling cause autoimmune diabetes and dysregulated Treg cell homeostasis. Proc Natl Acad Sci USA 110:6961–6966
Jun HS, Khil LY, Yoon JW (2002) Role of glutamic acid decarboxylase in the pathogenesis of type 1 diabetes. Cell Mol Life Sci 59:1892–1901
Kaufman DL, Clare-Salzler M, Tian J et al (1993) Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69–72
Kaufman DL, Tisch R, Sarvetnick N et al (2001) Report from the 1st international NOD mouse T-Cell workshop and the follow-up mini-workshop. Diabetes 50:2459–2463
Kim SK, Tarbell KV, Sanna M et al (2004) Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206–220-specific T cells. Proc Natl Acad Sci USA 101:14204–14209
Kim D, Lee SM, Jun HS (2017) Impact of T-cell-specific Smad4 deficiency on the development of autoimmune diabetes in NOD mice. Immunol Cell Biol 95:287–296
King C, Davies J, Mueller R et al (1998) TGF-beta1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. Immunity 8:601–613
Kitani A, Chua K, Nakamura K et al (2000) Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells. J Immunol 165:691–702
Ko HJ, Chee J, Sutherland RM et al (2014) Functional cytotoxic T lymphocytes against IGRP206-214 predict diabetes in the non-obese diabetic mouse. Immunol Cell Biol 92:640–644
Koevary SB (1991) Effects of incubation of islet cells with transforming growth factor beta (TGF-beta) on their susceptibility to diabetic lymphocyte mediated destruction in the rat, in vitro. Diabetes Res 18:123–127
Lernmark A, Larsson HE (2013) Immune therapy in type 1 diabetes mellitus. Nat Rev Endocrinol 9:92–103
Letterio JJ, Roberts AB (1998) Regulation of immune responses by TGF-beta. Annu Rev Immunol 16:137–161
Li MO, Wan YY, Sanjabi S et al (2006) Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24:99–146
Li MO, Wan YY, Flavell RA (2007) T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26:579–591
Lieberman SM, Evans AM, Han B et al (2003) Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc Natl Acad Sci USA 100:8384–8388
Mallone R, Brezar V, Boitard C (2011) T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives. Clin Dev Immunol 2011:513210
Maron R, Melican NS, Weiner HL (1999) Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes. J Autoimmun 12:251–258
Martin CC, Bischof LJ, Bergman B et al (2001) Cloning and characterization of the human and rat islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) genes. J Biol Chem 276:25197–25207
McCarron MJ, Marie JC (2014) TGF-β prevents T follicular helper cell accumulation and B cell autoreactivity. J Clin Invest 124:4375–4386
Mukherjee R, Chaturvedi P, Agrawal B et al (2003a) Regulation of type 1 diabetes by a self-MHC class II peptide: role of transforming growth factor beta (TGF-beta). Cell Mol Biol 49:159–169
Mukherjee R, Chaturvedi P, Qin HY et al (2003b) CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells. J Autoimmun 21:221–237
Mukherjee R, Wagar D, Stephens TA et al (2005) Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes. J Immunol 174:5306–5315
Murai M, Turovskaya O, Kim G et al (2009) Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol 10:1178–1184
Peakman M, von Herrath M (2010) Antigen-specific immunotherapy for type 1 diabetes: maximizing the potential. Diabetes 59:2087–2093
Pot C, Apetoh L, Kuchroo VK (2011) Type 1 regulatory T cells (Tr1) in autoimmunity. Semin Immunol 23:202–208
Quinn A, McInerney B, Reich EP et al (2001) Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes. J Immunol 166:2982–2991
Rabinovitch A (2003) Immunoregulation by cytokines in autoimmune diabetes. Adv Exp Med Biol 520:159–193
Rabinovitch A, Suarez-Pinzon WL (2007) Roles of cytokines in the pathogenesis and therapy of type 1 diabetes. Cell Biochem Biophys 48:159–163
Rabinovitch A, Suarez-Pinzon WL, Sorensen O et al (1997) TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice. J Immunol 159:6298–6303
Richer MJ, Straka N, Fang D et al (2008) Regulatory T-cells protect from type 1 diabetes after induction by coxsackievirus infection in the context of transforming growth factor-beta. Diabetes 57:1302–1311
Roep BO, Peakman M (2012) Antigen targets of type 1 diabetes autoimmunity. Cold Spring Harb Perspect Med 2:a007781
Sakaguchi S (2004) Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531–562
Sanjabi S, Oh SA, Li MO (2017) Regulation of the immune response by TGF-β: from conception to autoimmunity and infection. Cold Spring Harb Perspect Biol 9:a022236
Serra P, Santamaria P (2015) Nanoparticle-based autoimmune disease therapy. Clin Immunol 160:3–13
Singh B, Nikoopour E, Huszarik K et al (2011) Immunomodulation and regeneration of islet Beta cells by cytokines in autoimmune type 1 diabetes. J Interferon Cytokine Res 31:711–719
Singh B, Schwartz JA, Sandrock C et al (2013) Modulation of autoimmune diseases by interleukin (IL)-17 producing regulatory T helper (Th17) cells. Indian J Med Res 138:591–594
Stritesky GL, Jameson SC, Hogquist KA (2012) Selection of self-reactive T cells in the thymus. Annu Rev Immunol 30:95–114
Strober W, Kelsall B, Fuss I et al (1997) Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today 18:61–64
Suarez-Pinzon WL, Rabinovitch A (2001) Approaches to type 1 diabetes prevention by intervention in cytokine immunoregulatory circuits. Int J Exp Diabetes Res 2:3–17
Tisch R, Yang XD, Singer SM et al (1993) Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366:72–75
Tisch R, Wang B, Atkinson MA et al (2001) A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice. J Immunol 166:6925–6936
Travis MA, Sheppard D (2014) TGF-β activation and function in immunity. Annu Rev Immunol 32:51–82
Walker LS, von Herrath M (2016) CD4 T cell differentiation in type 1 diabetes. Clin Exp Immunol 183:16–29
Wan YY, Flavell RA (2006) The roles for cytokines in the generation and maintenance of regulatory T cells. Immunol Rev 212:114–130
Wong CP, Li L, Frelinger JA et al (2006) Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice. J Immunol 176:1637–1644
Yang J, Danke NA, Berger D et al (2006) Islet-specific glucose-6-phosphatase catalytic subunit-related protein-reactive CD4+ T cells in human subjects. J Immunol 176:2781–2789
Yang J, James EA, Sanda S et al (2013a) CD4+ T cells recognize diverse epitopes within GAD65: implications for repertoire development and diabetes monitoring. Immunology 138:269–279
Yang T, Hohenstein AC, Lee CE et al (2013b) Mapping I-A(g7) restricted epitopes in murine G6PC2. Immunol Res 55:91–99
You S, Thieblemont N, Alyanakian MA et al (2006) Transforming growth factor-beta and T-cell-mediated immunoregulation in the control of autoimmune diabetes. Immunol Rev 212:185–202
Zechel MA, Chaturvedi P, Singh B (1997) Characterization of immunodominant peptide determinants of IDDM-associated autoantigens in the NOD mouse. Res Immunol 148:338–348
Zechel MA, Elliott JF, Atkinson MA et al (1998a) Characterization of novel T-cell epitopes on 65 kDa and 67 kDa glutamic acid decarboxylase relevant in autoimmune responses in NOD mice. J Autoimmun 11:83–95
Zechel MA, Krawetz MD, Singh B (1998b) Epitope dominance: evidence for reciprocal determinant spreading to glutamic acid decarboxylase in non-obese diabetic mice. Immunol Rev 164:111–118
Zeng H, Zhang R, Jin B et al (2015) Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance. Cell Mol Immunol 12:566–571
Zhou X, Bailey-Bucktrout SL, Jeker LT et al (2009) Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 10:1000–1007
Acknowledgements
Studies in our laboratories were supported by grants from the Canadian Institutes of Health Research (CIHR) (to BS) and by NIH-DK-27722 (to EHL). We thank Olga Krougly (UWO) and Steve Langley for technical support (JAX).
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Singh, B., Krawetz, M.D., De Lima, R.M. et al. Role of TGF-β in Self-Peptide Regulation of Autoimmunity. Arch. Immunol. Ther. Exp. 66, 11–19 (2018). https://doi.org/10.1007/s00005-017-0482-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00005-017-0482-6